Oncology

Richmond, British Columbia -- You may now be able to diagnose cancer in a dog with a simple blood test.

Fort Collins, Colo. ?- Colorado State University is looking to build new cancer therapeutics from its liposome-targeting technology. The university and NeoTREX (a division of CSU Ventures) inked an exclusive option agreement with Joveis, Inc. of Napa, Calif. for the development of these therapeutics.

San Diego -- The U.S. Department of Agriculture (USDA) has granted full licensure to Oncept, a canine melanoma vaccine, to Vical Incorporated?s licensee Merial Limited.

Auburn, Ala. -- Quantum Immunologics Inc., a private biotechnology company, is collaborating with Auburn University to bring the school's cancer immunotherapy program to the veterinary market.

As the focus of cancer treatments shifts away from conventional chemotherapy to more targeted therapies, a new strategy for the treatment of cancer has become increasingly more popular for both human and veterinary patients.

Certain cases of cancer may respond well to conservative analgesic therapy initially but eventually require multimodal analgesia.

Dr. Ravinder Dhaliwahl says most veterinary oncologists prefer three thoracic radiographic views.

Using ultrasound guidance to perform fine-needle aspiration biopsy is preferred for tumors of the neck.

Owners are more positive about radiation therapy as a cancer treatment option than you might think.

A general review of lymphoma then discuss various novel therapies currently available for the palliation and control of this cancer in dogs.

Clinical trials are an important part of our profession.

A standard and reliable approach to the diagnosis of a cancer case typically will lead the experienced veterinarian to an answer.

Each year, thousands of compounds are screened for possible anticancer properties.

Primary lung cancer is uncommon in dogs, comprising around 1% of all cancer in this species.

Dogs and cats with cancer are typically presented by their owners either because of the physical presence of the mass if it is visible or palpable, or because of the effect of the cancer on the body and its functions.

Cancer chemotherapy is a relatively recent development in medical history.

Mast cell tumors (MCT) are among the most common tumors treated in dogs and are periodically seen in cats.

A general review of osteosarcoma then discuss various novel therapies currently available for the local and systemic treatment of this cancer in dogs.

Plasma cell neoplasms originate from terminally differentiated B lymphocytes that have undergone malignant transformation.

Another important form of neoplastic plasma cells are plasmacytomas, which arise from soft tissue, where they are known as extramedullary plasmacytomas, or from bone, where they are known as solitary osseous plasmacytomas.

Of the currently marketed feline vaccines, those against rabies and feline leukemia virus (FeLV) have been most commonly implicated in sarcoma development.

St. Paul, Minn. -- An experimental procedure to treat a dog with brain cancer that remains successful a year later has earned the University of Minnesota College of Veterinary Medicine funding to treat more dogs through clinical trials.

The majority of cytotoxic chemotherapy protocols in common veterinary use are designed to have a low risk of adverse effects.

Osteosarcoma (OSA) represents the most common bony tumor of dogs and cats.

Mast cell tumor (MCT) represents the most common malignant cutaneous tumor in the dog, and is commonly encountered in small animals.